Impact BioMedical, Inc. (IBO)
3.55
-0.18
(-4.83%)
USD |
NYAM |
Oct 27, 16:00
3.91
+0.36
(+10.14%)
Pre-Market: 08:51
Impact BioMedical Market Cap : 30.33M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 30.33M |
| October 26, 2026 | 31.87M |
| October 23, 2026 | 30.76M |
| October 22, 2026 | 32.47M |
| October 21, 2026 | 34.35M |
| October 20, 2026 | 27.92M |
| October 19, 2026 | 26.14M |
| October 16, 2026 | 22.90M |
| October 15, 2026 | 26.98M |
| October 14, 2026 | 29.08M |
| October 13, 2026 | 34.00M |
| October 12, 2026 | 34.43M |
| October 09, 2026 | 36.31M |
| October 08, 2026 | 35.11M |
| October 07, 2026 | 38.28M |
| October 06, 2026 | 39.98M |
| October 05, 2026 | 41.35M |
| October 02, 2026 | 45.45M |
| October 01, 2026 | 46.39M |
| September 30, 2026 | 47.84M |
| September 29, 2026 | 47.84M |
| September 28, 2026 | 47.93M |
| September 25, 2026 | 48.61M |
| September 24, 2026 | 48.27M |
| September 23, 2026 | 56.64M |
| Date | Value |
|---|---|
| September 22, 2026 | 56.89M |
| September 21, 2026 | 59.92M |
| September 18, 2026 | 63.61M |
| September 17, 2026 | 777.51M |
| September 16, 2026 | 677.63M |
| September 15, 2026 | 719.82M |
| September 14, 2026 | 658.72M |
| September 11, 2026 | 626.20M |
| September 10, 2026 | 600.07M |
| September 09, 2026 | 671.78M |
| September 08, 2026 | 680.35M |
| September 04, 2026 | 734.78M |
| September 03, 2026 | 653.14M |
| September 02, 2026 | 666.75M |
| September 01, 2026 | 623.20M |
| August 31, 2026 | 627.46M |
| August 28, 2026 | 603.75M |
| August 27, 2026 | 600.07M |
| August 26, 2026 | 598.85M |
| August 25, 2026 | 626.20M |
| August 24, 2026 | 616.40M |
| August 21, 2026 | 653.14M |
| August 20, 2026 | 611.37M |
| August 19, 2026 | 589.46M |
| August 18, 2026 | 639.53M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| LENZ Therapeutics, Inc. | 98.96M |
| Enveric Biosciences, Inc. | 5.589M |
| ANI Pharmaceuticals, Inc. | 1.635B |
| Corcept Therapeutics, Inc. | 9.453B |
| Veru, Inc. | 38.87M |
Market Cap Related Metrics
| PS Ratio | 667.91 |
| Price to Book Value | 2.817 |
| Price | 3.55 |
| Earnings Yield | -34.92% |